Skip to main content
. 2021 Nov 30;12(2):11030–11040. doi: 10.1080/21655979.2021.2005895

Figure 2.

Figure 2.

Zafirlukast mitigated Docetaxel-induced mitochondrial dysfunction in LO-2 hepatocytes. (a). Mitochondrial membrane potential (ΔΨm) was measured using RH123 staining; (b). The levels of intracellular ATP (####, P < 0.0001 vs. control group; **, ***, P < 0.01, 0.005 vs. Docetaxel group)